Truncation of Macrophage-derived Chemokine by CD26/ Dipeptidyl-Peptidase IV beyond Its Predicted Cleavage Site Affects Chemotactic Activity and CC Chemokine Receptor 4 Interaction-Reference-Cited by-同舟云学术

Truncation of Macrophage-derived Chemokine by CD26/ Dipeptidyl-Peptidase IV beyond Its Predicted Cleavage Site Affects Chemotactic Activity and CC Chemokine Receptor 4 Interaction

Published:1999-02 Issue:7 Volume:274 Page:3988-3993
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Proost Paul,Struyf Sofie,Schols Dominique,Opdenakker Ghislain,Sozzani Silvano,Allavena Paola,Mantovani Alberto,Augustyns Koen,Bal Gunther,Haemers Achiel,Lambeir Anne-Marie,Scharpé Simon,Van Damme Jo,De Meester Ingrid

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference32 articles.

1. Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway

2. The structure and function of CD26 in the T-cell immune response

3. Proline-Dependent Structural and Biological Properties of Peptides and Proteins

4. Proline motifs in peptides and their biological processing

5. Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dipeptidyl peptidase IV: a multifunctional enzyme with implications in several pathologies including cancer;Physical Sciences Reviews;2023-05-11

2. The Mycobacterium tuberculosis prolyl dipeptidyl peptidase cleaves the N-terminal peptide of the immunoprotein CXCL-10;Biological Chemistry;2023-01-12

3. The role of insulin and incretin-based drugs in biliary tract cancer: epidemiological and experimental evidence;Discover Oncology;2022-08-07

4. Biochemical characterization of a Mycobacterium tuberculosis prolyl dipeptidyl peptidase that displays a remarkable thermostability;2022-07-09

5. Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-06